201 related articles for article (PubMed ID: 21411577)
21. Poliovirus vaccine strains detected in stool specimens of immunodeficient children in South Africa.
Pavlov DN; Van Zyl WB; Kruger M; Blignaut L; Grabow WO; Ehlers MM
Diagn Microbiol Infect Dis; 2006 Jan; 54(1):23-30. PubMed ID: 16290028
[TBL] [Abstract][Full Text] [Related]
22. Paralytic poliomyelitis associated with the Sabin 3 revertant strain of poliovirus in Bahrain.
Khalfan SA; Chomel JJ; Mallet L; Fernandes E; Lahlou AI; Lina B; Aymard M
Ann Trop Paediatr; 2001 Sep; 21(3):223-9. PubMed ID: 11579860
[TBL] [Abstract][Full Text] [Related]
23. Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication.
Minor P
Vaccine; 2009 May; 27(20):2649-52. PubMed ID: 19428874
[TBL] [Abstract][Full Text] [Related]
24. Global eradication of poliomyelitis: reinvent the wheel or use existing options effectively?
Ogra PL
Public Health Rev; 1993-1994; 21(1-2):143-50. PubMed ID: 8041881
[TBL] [Abstract][Full Text] [Related]
25. Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccine after prior immunization with inactivated polio vaccine.
Abraham R; Minor P; Dunn G; Modlin JF; Ogra PL
J Infect Dis; 1993 Nov; 168(5):1105-9. PubMed ID: 8228342
[TBL] [Abstract][Full Text] [Related]
26. Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden.
Platt LR; Estívariz CF; Sutter RW
J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S380-9. PubMed ID: 25316859
[TBL] [Abstract][Full Text] [Related]
27. Analysis of reversions in the 5'-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines.
Laassri M; Lottenbach K; Belshe R; Rennels M; Plotkin S; Chumakov K
J Infect Dis; 2006 May; 193(10):1344-9. PubMed ID: 16619180
[TBL] [Abstract][Full Text] [Related]
28. Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine.
Wattigney WA; Mootrey GT; Braun MM; Chen RT
Pediatrics; 2001 May; 107(5):E83. PubMed ID: 11331733
[TBL] [Abstract][Full Text] [Related]
29. Molecular Characterization of Polio from Environmental Samples: ISSP, The Israeli Sewage Surveillance Protocol.
Shulman LM; Manor Y; Hindiyeh M; Sofer D; Mendelson E
Methods Mol Biol; 2016; 1387():55-107. PubMed ID: 26983731
[TBL] [Abstract][Full Text] [Related]
30. Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis.
Swartz TA; Handsher R; Manor Y; Stoeckel P; Barkay A; Mendelson E; Leventhal A
Vaccine; 1998 Dec; 16(20):2090-5. PubMed ID: 9796069
[TBL] [Abstract][Full Text] [Related]
31. Detection of vaccine-derived polioviruses in Mexico using environmental surveillance.
Esteves-Jaramillo A; Estívariz CF; Peñaranda S; Richardson VL; Reyna J; Coronel DL; Carrión V; Landaverde JM; Wassilak SG; Pérez-Sánchez EE; López-Martínez I; Burns CC; Pallansch MA
J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S315-23. PubMed ID: 25316850
[TBL] [Abstract][Full Text] [Related]
32. Poliovirus vaccine strains in sewage and river water in South Africa.
Pavlov DN
Can J Microbiol; 2006 Aug; 52(8):717-23. PubMed ID: 16917529
[TBL] [Abstract][Full Text] [Related]
33. Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India.
Chowdhary R; Dhole TN
J Med Virol; 2008 Aug; 80(8):1477-88. PubMed ID: 18551602
[TBL] [Abstract][Full Text] [Related]
34. Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge.
Hird TR; Grassly NC
PLoS Pathog; 2012; 8(4):e1002599. PubMed ID: 22532797
[TBL] [Abstract][Full Text] [Related]
35. Spatial Analyses of Oral Polio Vaccine Transmission in an Community Vaccinated With Inactivated Polio Vaccine.
Jarvis CI; Altamirano J; Sarnquist C; Edmunds WJ; Maldonado Y
Clin Infect Dis; 2018 Oct; 67(suppl_1):S18-S25. PubMed ID: 30376089
[TBL] [Abstract][Full Text] [Related]
36. Cluster survey evaluation of coverage and risk factors for failure to be immunized during the 1995 National Immunization Days in Egypt.
Reichler MR; Darwish A; Stroh G; Stevenson J; Al Nasr MA; Oun SA; Wahdan MH
Int J Epidemiol; 1998 Dec; 27(6):1083-9. PubMed ID: 10024208
[TBL] [Abstract][Full Text] [Related]
37. Modeling options to manage type 1 wild poliovirus imported into Israel in 2013.
Kalkowska DA; Duintjer Tebbens RJ; Grotto I; Shulman LM; Anis E; Wassilak SG; Pallansch MA; Thompson KM
J Infect Dis; 2015 Jun; 211(11):1800-12. PubMed ID: 25505296
[TBL] [Abstract][Full Text] [Related]
38. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
Pliaka V; Kyriakopoulou Z; Markoulatos P
Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246
[TBL] [Abstract][Full Text] [Related]
39. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E
Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
[TBL] [Abstract][Full Text] [Related]
40. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
